Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: lack of effect.

Webb JG, Pate GE, Humphries KH, Buller CE, Shalansky S, Al Shamari A, Sutander A, Williams T, Fox RS, Levin A.

Am Heart J. 2004 Sep;148(3):422-9.

PMID:
15389228
2.

N-acetylcysteine for the prevention of contrast-induced nephropathy in patients with pre-existing renal insufficiency or diabetes: a systematic review and meta-analysis.

Kang X, Hu DY, Li CB, Ai ZS, Peng A.

Ren Fail. 2015 Nov;37(10):297-303. doi: 10.3109/0886022X.2015.1012985. Epub 2015 Oct 13. Review.

PMID:
26458505
3.

Sodium bicarbonate plus N-acetylcysteine prophylaxis: a meta-analysis.

Brown JR, Block CA, Malenka DJ, O'Connor GT, Schoolwerth AC, Thompson CA.

JACC Cardiovasc Interv. 2009 Nov;2(11):1116-24. doi: 10.1016/j.jcin.2009.07.015. Review.

4.

Trimetazidine Decreases Risk of Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease: A Meta-Analysis of Randomized Controlled Trials.

Nadkarni GN, Konstantinidis I, Patel A, Yacoub R, Kumbala D, Patel RA, Annapureddy N, Pakanati KC, Simoes PK, Javed F, Benjo AM.

J Cardiovasc Pharmacol Ther. 2015 Nov;20(6):539-46. doi: 10.1177/1074248415573320. Epub 2015 Feb 24. Review.

PMID:
25715308
5.

Systematic review of the impact of N-acetylcysteine on contrast nephropathy.

Pannu N, Manns B, Lee H, Tonelli M.

Kidney Int. 2004 Apr;65(4):1366-74. Review.

6.

Oral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography. A randomized controlled trial and review of the current literature.

Goldenberg I, Shechter M, Matetzky S, Jonas M, Adam M, Pres H, Elian D, Agranat O, Schwammenthal E, Guetta V.

Eur Heart J. 2004 Feb;25(3):212-8. Review.

PMID:
14972421
7.

Current concepts of contrast-induced nephropathy: a brief review.

Chang CF, Lin CC.

J Chin Med Assoc. 2013 Dec;76(12):673-81. doi: 10.1016/j.jcma.2013.08.011. Epub 2013 Oct 3. Review.

8.

The effectiveness of N-Acetylcysteine in preventing contrast-induced nephropathy in patients undergoing contrast-enhanced computed tomography: a meta-analysis of randomized controlled trials.

Wu MY, Hsiang HF, Wong CS, Yao MS, Li YW, Hsiang CY, Bai CH, Hsu YH, Lin YF, Tam KW.

Int Urol Nephrol. 2013 Oct;45(5):1309-18. doi: 10.1007/s11255-012-0363-1. Epub 2013 Jan 3. Review.

PMID:
23283594
9.

High-dose statin pretreatment for the prevention of contrast-induced nephropathy: a meta-analysis.

Zhang BC, Li WM, Xu YW.

Can J Cardiol. 2011 Nov-Dec;27(6):851-8. doi: 10.1016/j.cjca.2011.05.005. Epub 2011 Sep 22. Review.

PMID:
21944277
10.

The effect of N-acetylcysteine on the incidence of contrast-induced kidney injury: A systematic review and trial sequential analysis.

Wang N, Qian P, Kumar S, Yan TD, Phan K.

Int J Cardiol. 2016 Apr 15;209:319-27. doi: 10.1016/j.ijcard.2016.02.083. Epub 2016 Feb 16. Review.

PMID:
26922293
11.

Prevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trial.

Weisbord SD, Gallagher M, Kaufman J, Cass A, Parikh CR, Chertow GM, Shunk KA, McCullough PA, Fine MJ, Mor MK, Lew RA, Huang GD, Conner TA, Brophy MT, Lee J, Soliva S, Palevsky PM.

Clin J Am Soc Nephrol. 2013 Sep;8(9):1618-31. doi: 10.2215/CJN.11161012. Epub 2013 May 9. Review.

12.

Side effects of radiographic contrast media: pathogenesis, risk factors, and prevention.

Andreucci M, Solomon R, Tasanarong A.

Biomed Res Int. 2014;2014:741018. doi: 10.1155/2014/741018. Epub 2014 May 11. Review.

13.

Role of N-acetylcysteine in the prevention of radiocontrast-induced nephropathy.

Brophy DF.

Ann Pharmacother. 2002 Sep;36(9):1466-70. Review.

PMID:
12196069
14.

Intravenous Contrast-Induced Nephropathy-The Rise and Fall of a Threatening Idea.

Luk L, Steinman J, Newhouse JH.

Adv Chronic Kidney Dis. 2017 May;24(3):169-175. doi: 10.1053/j.ackd.2017.03.001. Review.

PMID:
28501080
15.

Early ambulation strategies with contrast management.

Lim MJ.

J Invasive Cardiol. 2005 Jan;17(1):42-3; quiz 44. Review. No abstract available.

PMID:
15640540
16.

Race and contrast-induced nephropathy in patients undergoing coronary angiography and cardiac catheterization.

Chawla R, Turlington J, Arora P, Jovin IS.

Int J Cardiol. 2017 Mar 1;230:610-613. doi: 10.1016/j.ijcard.2016.12.046. Epub 2016 Dec 23. Review.

PMID:
28040287

Supplemental Content

Support Center